TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C

Journal of Medical Virology

Volumn 81, Issue 7, 2009, Pages 1204-1211

  Askar, Eva ^a   Bregadze, Rusudan ^a   Mertens, Jasmin ^a   Schweyer, Stefan ^a   Rosenberger, Albert ^a   Ramadori, Giuliano ^a   Mihm, Sabine ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

HCV genotypes; Hepatitis C virus (HCV); L412F; Single nucleotide polymorphism (SNP); T 976A; Toll like receptor (TLR)

Indexed keywords

ADENINE; CYTOSINE; THYMINE; TOLL LIKE RECEPTOR 3; TLR3 PROTEIN, HUMAN;

ADULT; ARTICLE; CHRONIC HEPATITIS; DISEASE PREDISPOSITION; EXON; FEMALE; GENE; GENE EXPRESSION; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TLR3 GENE; GENETICS; HEPATITIS C VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; MISSENSE MUTATION; PATHOLOGY; POINT MUTATION;

HEPATITIS C VIRUS;

ADULT; EXONS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TOLL-LIKE RECEPTOR 3;

EID: 67649979735     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21491     Document Type: Article

References (31)

1. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
2. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738. (Pubitemid 33009951)
3. Ball TB, Ji H, Kimani J, McLaren P, Marlin C, Hill AV, Plummer FA. 2007. Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 21:1091-1101. (Pubitemid 46763279)
4. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362. (Pubitemid 19117877)
5. Cook DN, Pisetsky DS, Schwartz DA. 2004. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5:975-979. (Pubitemid 41057713)
6. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. 1994. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513-1520. (Pubitemid 24166476)
7. Dhiman N, Ovsyannikova IG, Vierkant RA, Ryan JE, Pankratz VS, Jacobson RM, Poland GA. 2008. Associations between SNPs in tolllike receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary results.Vaccine 26:1731-1736.
8. El-Omar EM, Ng MT, Hold GL. 2008. Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene 27:244-252.
9. Fukata M, Abreu MT. 2008. Role of Toll-like receptors in gastrointestinal malignancies. Oncogene 27:234-243.
10. Gale M, Jr., Foy EM. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436:939-945. (Pubitemid 41191669)
11. Matsumoto M, Funami K, Oshiumi H, Seya T. 2004. Toll-like receptor 3: A link between toll-like receptor, interferon and viruses. Microbiol Immunol 48:147-154. (Pubitemid 38405076)
12. Micallef JM, Kaldor JM, Dore GJ. 2006. Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. J Viral Hepat 13:34-41.
13. Mihm S, Hartmann H, Fayyazi A, Ramadori G. 1996a. Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio. Dig Dis Sci 41:1256-1264. (Pubitemid 26227902)
14. Mihm S, Hutschenreiter A, Fayyazi A, Pingel S, Ramadori G. 1996b. High inflammatory activity is associated with an increased amount of IFN-gamma transcripts in peripheral blood cells of patients with chronic hepatitis C virus infection. Med Microbiol Immunol 185: 95-102. (Pubitemid 26302541)
15. Mihm S, Fayyazi A, Hartmann H, Ramadori G. 1997. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 25:735-739. (Pubitemid 27106462)
16. Mihm S, Frese M, Meier V, Wietzke-Braun P, Scharf JG, Bartenschlager R, Ramadori G. 2004. Interferon type I gene expression in chronic hepatitis C. Lab Invest 84:1148-1159. (Pubitemid 39128260)
17. Ranjith-Kumar CT, Miller W, Sun J, Xiong J, Santos J, Yarbrough I, Lamb RJ,Mills J, Duffy KE, Hoose S, Cunningham M, Holzenburg A, Mbow ML, Sarisky RT, Kao CC. 2007. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J Biol Chem 282:17696-17705. (Pubitemid 47100325)
18. Risch NJ. 2000. Searching for genetic determinants in the new millennium. Nature 405:847-856. (Pubitemid 30407863)
19. Santoro MG, Rossi A, Amici C. 2003. NF-kappaB and virus infection: Who controls whom. EMBO J 22:2552-2560. (Pubitemid 36712353)
20. Schott E, Witt H, Neumann K, Taube S, Oh DY, Schreier E, Vierich S, Puhl G, BergkA,Halangk J, Weich V, WiedenmannB, Berg T. 2007. A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. J Hepatol 47:203-211. (Pubitemid 47021254)
21. Schott E, Witt H, Neumann K, Bergk A, Halangk J,Weich V,Muller T, Puhl G, Wiedenmann B, Berg T. 2008. Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy. J Viral Hepat 15:71-78. (Pubitemid 350243584)
22. Schulz O, Diebold SS, Chen M, Naslund TI, Nolte MA, Alexopoulou L, Azuma YT, Flavell RA, Liljestrom P, Reis e Sousa C. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433:887-892.
23. Seeff LB. 2002. Natural history of chronic hepatitis C. Hepatology 36:S35-S46.
24. Seki E, Brenner DA. 2008. Toll-like receptors and adaptor molecules in liver disease: Update. Hepatology 48:322-335. (Pubitemid 351975556)
25. ShepardCW,Finelli L, Alter MJ.2005.Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558-567. (Pubitemid 41196755)
26. + T lymphocytes express TLR3 as a functional coreceptor. J Immunol 177:8708-8713. (Pubitemid 44893836)
27. Takeuchi O, Akira S. 2007. Recognition of viruses by innate immunity. Immunol Rev 220:214-224.
28. Vercammen E, Staal J, Beyaert R. 2008. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 21:13-25. (Pubitemid 351160008)
29. Wesch D, Beetz S, Oberg HH, Marget M, Krengel K, Kabelitz D. 2006. Direct costimulatory effect of TLR3 ligand poly(I:C) on human gamma delta T lymphocytes. J Immunol 176:1348-1354. (Pubitemid 43134276)
30. Wietzke-Braun P, Maouzi AB,Manhardt LB, BickebollerH, Ramadori G, Mihm S. 2006. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection. Eur J Gastroenterol Hepatol 18:991-997. (Pubitemid 44213043)
31. Wornle M, Schmid H, Banas B, Merkle M, Henger A, Roeder M, Blattner S, Bock E, Kretzler M, Grone HJ, Schlondorff D. 2006. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168:370-385. (Pubitemid 43271137)